Baxter International (BAX) Net Margin (2009 - 2026)
Baxter International's (BAX) quarterly Net Margin came in at 4.26% in Q2 2026, up 102.0% year-over-year from 2.11% in Q2 2025, and up 866.5% quarter-over-quarter from 0.56% in Q1 2026.
Analysis
Baxter International (BAX) Net Margin (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Net Margin for 18 consecutive years, with 4.26% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin rose 102.0% year-over-year to 4.26% in Q2 2026; TTM through Jun 2026 was 0.21%, a 235.0% decrease from a year earlier, with the FY2025 full-year figure at 8.51%, down 251.0% from the prior year.
- Net Margin was 4.26% for Q2 2026 at Baxter International, up from 0.56% in the prior quarter.
- Over five years, Net Margin peaked at 97.15% in Q3 2023 and troughed at 81.3% in Q3 2022.
- A 5-year average of 1.64% and a median of 3.16% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin tumbled 9531 bps in 2022 and soared 17845 bps in 2023, its largest moves.
- Over 5 years, Net Margin stood at 7.32% in 2022, then soared by 275 bps to 12.83% in 2023, then sank by 106 bps to 0.8% in 2024, then jumped by 505 bps to 3.24% in 2025, then soared by 31 bps to 4.26% in 2026.
- The last three Net Margin figures came in at 4.26% (Q2 2026), 0.56% (Q1 2026), and 3.24% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 50.32 Bn | 49.46 Bn | 2.32 Bn | 7.59% |
| 2 | Medline | 48.11 Bn | 52.93 Bn | 2.22 Bn | 1.81% |
| 3 | West Pharmaceutical Services | 23.93 Bn | 23.49 Bn | 329.20 Mn | 16.96% |
| 4 | Baxter International | 13.34 Bn | 11.16 Bn | 1.03 Bn | 4.26% |
| 5 | Stevanato Group S.p.A | 6.21 Bn | 6.11 Bn | 100.91 Mn | 7.60% |
| 6 | Acme United | 241.34 Mn | 236.30 Mn | 26.69 Mn | 8.05% |
| 7 | Rockwell Medical | 31.74 Mn | 6.94 Mn | 3.24 Mn | -7.32% |
| 8 | Retractable Technologies | 21.26 Mn | -18.61 Mn | 190,852.00 | 38.51% |
| 9 | United Health Products | 12.24 Mn | 12.21 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 8.09 Mn | 4.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26% |
| Mar 31, 2026 | -0.56% |
| Jun 30, 2025 | 3.24% |
| Mar 31, 2025 | 4.80% |
| Dec 31, 2024 | -0.80% |
| Sep 30, 2024 | 3.08% |
| Jun 30, 2024 | -15.07% |
| Mar 31, 2024 | 2.89% |
| Dec 31, 2023 | 12.83% |
| Sep 30, 2023 | 97.15% |
| Jun 30, 2023 | -11.77% |
| Mar 31, 2023 | 3.81% |
| Dec 31, 2022 | -7.32% |
| Sep 30, 2022 | -81.30% |
| Jun 30, 2022 | 7.10% |
| Mar 31, 2022 | 3.88% |
| Dec 31, 2021 | -0.70% |
| Sep 30, 2021 | 14.01% |
| Jun 30, 2021 | 9.72% |
| Mar 31, 2021 | 10.18% |